Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-27 Sale |
2025-03-28 4:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
138,574 | $6.04 | $836,987 | 11,174,028 (Indirect Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 4:16 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $6.475 | $259,000 | 17,229,302 (Indirect Direct) |
View |
| 2025-02-05 Sale |
2025-02-07 4:14 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $7.9 | $316,000 | 17,326,434 (Indirect Direct) |
View |
| 2025-01-08 Sale |
2025-01-13 5:26 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $7.18 | $287,200 | 15,819,344 (Indirect Direct) |
View |
| 2024-12-04 Sale |
2024-12-06 5:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $7.14 | $285,600 | 15,899,344 (Indirect Direct) |
View |
| 2024-11-13 Sale |
2024-11-15 6:52 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $7.545 | $301,800 | 16,005,367 (Indirect Direct) |
View |
| 2024-10-02 Sale |
2024-10-04 6:30 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $6.12 | $244,800 | 16,085,367 (Indirect Direct) |
View |
| 2024-09-04 Sale |
2024-09-06 4:57 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $6.09 | $243,600 | 16,165,367 (Indirect Direct) |
View |
| 2024-08-07 Sale |
2024-08-09 4:56 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
50,000 | $6.86 | $343,000 | 16,271,449 (Indirect Direct) |
View |
| 2024-07-10 Sale |
2024-07-12 6:54 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $7.475 | $747,500 | 16,401,449 (Indirect Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 4:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $8.71 | $871,000 | 10,249,749 (Indirect Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 6:24 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $8.1 | $810,000 | 10,400,831 (Indirect Direct) |
View |
| 2024-04-03 Sale |
2024-04-05 5:44 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
130,000 | $8.93 | $1,160,900 | 4,077,835 (Indirect Direct) |
View |
| 2024-03-28 Sale |
2024-04-01 6:40 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
65,000 | $10.1 | $656,500 | 4,232,835 (Indirect Direct) |
View |
| 2024-03-06 Sale |
2024-03-08 7:08 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
61,319 | $11.73 | $719,505 | 10,784,331 (Indirect Direct) |
View |
| 2024-02-07 Sale |
2024-02-09 5:34 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
48,272 | $9.2182 | $444,981 | 9,858,536 (Indirect Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 8:03 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
55,853 | $9.4994 | $530,567 | 9,916,808 (Indirect Direct) |
View |
| 2023-12-06 Sale |
2023-12-08 5:22 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
59,829 | $7.4946 | $448,394 | 9,982,661 (Indirect Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 6:14 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
62,177 | $5.1675 | $321,301 | 10,079,403 (Indirect Direct) |
View |
| 2023-10-04 Sale |
2023-10-06 6:12 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
59,794 | $7.2085 | $431,025 | 10,141,580 (Indirect Direct) |
View |
| 2023-09-06 Sale |
2023-09-08 5:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
58,765 | $8.8053 | $517,442 | 10,211,374 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-05 Conversion |
2025-03-07 4:16 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 17,229,302 (Direct) |
View |
| 2025-02-18 Tax Withholding |
2025-02-20 4:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
17,132 | $10.64 | 11,352,602 (Direct) |
View |
| 2025-02-05 Conversion |
2025-02-07 4:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 17,326,434 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 4:50 pm |
N/A 2035-02-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,592,659 | $0 | 10,742,836 (Direct) |
View |
| 2025-02-03 Tax Withholding |
2025-02-05 4:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,569 | $7.25 | 10,742,836 (Direct) |
View |
| 2025-01-08 Conversion |
2025-01-13 5:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 15,819,344 (Direct) |
View |
| 2024-12-04 Conversion |
2024-12-06 5:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 15,899,344 (Direct) |
View |
| 2024-11-15 Tax Withholding |
2024-11-19 6:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
26,023 | $6.175 | 9,902,644 (Direct) |
View |
| 2024-11-13 Conversion |
2024-11-15 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 16,005,367 (Direct) |
View |
| 2024-10-02 Conversion |
2024-10-04 6:30 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 16,085,367 (Direct) |
View |
| 2024-09-04 Conversion |
2024-09-06 4:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
40,000 | $0 | 16,165,367 (Direct) |
View |
| 2024-08-30 Exercise |
2024-08-30 4:26 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-30 Exercise |
2024-08-30 4:26 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-29 Exercise |
2024-08-29 4:22 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-29 Exercise |
2024-08-29 4:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-28 4:12 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-28 Exercise |
2024-08-28 4:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-27 Exercise |
2024-08-27 4:10 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-27 Exercise |
2024-08-27 4:10 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-26 4:42 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-26 Exercise |
2024-08-26 4:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-23 5:25 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $0 | 10,048,667 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-23 5:25 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
5,000 | $2.48 | 10,048,667 (Direct) |
View |
| 2024-08-15 Tax Withholding |
2024-08-19 7:09 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
26,082 | $6.69 | 10,048,667 (Direct) |
View |
| 2024-08-07 Conversion |
2024-08-09 4:56 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
50,000 | $0 | 16,271,449 (Direct) |
View |
| 2024-07-10 Conversion |
2024-07-12 6:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $0 | 16,401,449 (Direct) |
View |
| 2024-07-10 Gift |
2024-07-12 6:54 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 16,401,449 (Direct) |
View |
| 2024-06-05 Conversion(A) |
2024-07-12 6:52 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $0 | 7,235,438 (Direct) |
View |
| 2024-06-05 Conversion |
2024-06-07 4:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,249,749 (Direct) |
View |
| 2024-06-05 Gift |
2024-06-07 4:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,249,749 (Direct) |
View |
| 2024-05-15 Tax Withholding |
2024-05-17 7:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
26,082 | $10.01 | 10,374,749 (Direct) |
View |
| 2024-05-02 Conversion |
2024-05-03 6:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,296 | $0 | 10,400,831 (Direct) |
View |
| 2024-05-01 Gift |
2024-05-03 6:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,400,831 (Direct) |
View |
| 2024-04-03 Conversion |
2024-04-05 5:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
50,000 | $0 | 4,077,835 (Indirect) |
View |
| 2024-04-03 Gift |
2024-04-05 5:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 4,077,835 (Direct) |
View |
| 2024-03-28 Exercise |
2024-04-01 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 4,232,835 (Indirect) |
View |
| 2024-03-28 Conversion |
2024-04-01 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 4,232,835 (Indirect) |
View |
| 2024-03-28 Gift |
2024-04-01 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 4,232,835 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 7:08 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,924 | $0 | 10,784,331 (Direct) |
View |
| 2024-03-06 Conversion |
2024-03-08 7:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
35,000 | $0 | 10,784,331 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 7:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,784,331 (Direct) |
View |
| 2024-03-06 Gift |
2024-03-08 7:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,784,331 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 7:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
8,674 | $11.4 | 10,784,331 (Direct) |
View |
| 2024-02-15 Tax Withholding |
2024-02-16 7:57 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
11,148 | $12.43 | 1,104,919 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-13 6:55 pm |
N/A 2034-02-09 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
1,011,495 | $0 | 10,866,798 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 6:55 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
3,233 | $10.09 | 10,866,798 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:34 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,858,536 (Direct) |
View |
| 2024-02-07 Conversion |
2024-02-09 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,858,536 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,858,536 (Direct) |
View |
| 2024-02-07 Gift |
2024-02-09 5:34 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,858,536 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-05 8:03 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,916,808 (Direct) |
View |
| 2024-01-03 Conversion |
2024-01-05 8:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
35,000 | $0 | 9,916,808 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-05 8:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,916,808 (Direct) |
View |
| 2024-01-03 Gift |
2024-01-05 8:03 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,916,808 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-08 5:22 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 9,982,661 (Direct) |
View |
| 2023-12-06 Conversion |
2023-12-08 5:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,982,661 (Direct) |
View |
| 2023-12-06 Exercise |
2023-12-08 5:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 9,982,661 (Direct) |
View |
| 2023-12-06 Gift |
2023-12-08 5:22 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 9,982,661 (Direct) |
View |
| 2023-11-15 Conversion |
2023-11-17 5:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,052,490 (Direct) |
View |
| 2023-11-15 Tax Withholding |
2023-11-17 5:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
16,913 | $7.18 | 10,052,490 (Direct) |
View |
| 2023-11-15 Gift |
2023-11-17 5:50 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,052,490 (Direct) |
View |
| 2023-11-01 Exercise |
2023-11-03 6:14 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,079,403 (Direct) |
View |
| 2023-11-01 Conversion |
2023-11-03 6:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,079,403 (Indirect) |
View |
| 2023-11-01 Exercise |
2023-11-03 6:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,079,403 (Direct) |
View |
| 2023-10-16 Conversion |
2023-10-18 5:33 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,131,580 (Direct) |
View |
| 2023-10-16 Gift |
2023-10-18 5:33 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,131,580 (Direct) |
View |
| 2023-10-04 Exercise |
2023-10-06 6:12 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,141,580 (Direct) |
View |
| 2023-10-04 Exercise |
2023-10-06 6:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,141,580 (Direct) |
View |
| 2023-09-15 Conversion |
2023-09-19 5:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,201,374 (Direct) |
View |
| 2023-09-15 Gift |
2023-09-19 5:49 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,201,374 (Direct) |
View |
| 2023-09-06 Exercise |
2023-09-08 5:01 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $0 | 10,211,374 (Direct) |
View |
| 2023-09-06 Conversion |
2023-09-08 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,211,374 (Indirect) |
View |
| 2023-09-06 Exercise |
2023-09-08 5:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,211,374 (Direct) |
View |
| 2023-08-15 Tax Withholding |
2023-08-17 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
16,913 | $9.19 | 873,806 (Direct) |
View |
| 2023-08-09 Conversion |
2023-08-11 4:59 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,326,976 (Direct) |
View |
| 2023-08-09 Gift |
2023-08-11 4:59 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,326,976 (Direct) |
View |